Corrections. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

Lancet Respir Med. 2015 Apr;3(4):e15. doi: 10.1016/S2213-2600(15)00119-8. Epub 2015 Apr 5.
No abstract available

Publication types

  • Published Erratum